Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fluorescent PSMA-Targeted Radiotheranostic Compounds for Multiscale Imaging.

Bioconjugate chemistry·2025
Same author

Localized <i>in vivo</i> prodrug activation using radionuclides.

bioRxiv : the preprint server for biology·2024
Same author

Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia.

The Science of the total environment·2023
Same author

Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study.

Revista clinica espanola·2021
Same author

Discordance in treatment of chronic obstructive pulmonary disease following GesEPOC guideline vs. GOLD.

Revista clinica espanola·2021
Same author

[Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study].

Revista clinica espanola·2021

Related Experiment Video

Updated: Jul 19, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

A simple score for assessing stable chronic obstructive pulmonary disease.

C Esteban1, J M Quintana, M Aburto

  • 1Pneumology Service, Hospital de Galdakao, Barrio Labeaga s/n 48960, Galdakao, Bizkaia, Spain. cristobal_esteban@yahoo.es

QJM : Monthly Journal of the Association of Physicians
|October 13, 2006
PubMed
Summary

The Health-Activity-Dyspnoea-Obstruction (HADO) score effectively classifies chronic obstructive pulmonary disease (COPD) severity and predicts patient survival. This score is more accurate than FEV1 alone for assessing COPD outcomes.

Related Experiment Videos

Last Updated: Jul 19, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Area of Science:

  • Pulmonary Medicine
  • Clinical Research
  • Health Outcomes

Background:

  • Chronic obstructive pulmonary disease (COPD) diagnosis and severity traditionally rely on FEV1 measurements.
  • COPD is increasingly recognized as a systemic disease with multifaceted impacts.
  • Current assessment methods may not fully capture the complexity of COPD.

Purpose of the Study:

  • To evaluate the Health-Activity-Dyspnoea-Obstruction (HADO) score for COPD severity classification.
  • To assess the HADO score's utility in predicting patient outcomes, including mortality.
  • To compare the HADO score's predictive power against FEV1 alone.

Main Methods:

  • A prospective longitudinal study involving 611 stable COPD patients across five outpatient clinics.
  • Data collection included dyspnea, pulmonary function (spirometry), physical activity, and overall health.
  • Outcome measures comprised health-related quality of life (HRQoL) and 3-year mortality.

Main Results:

  • The HADO score classified patients into mild (26.7%), moderate (53.3%), and severe (20%) COPD.
  • Significant correlations were observed between HADO severity levels and HRQoL and vital status.
  • The HADO score reliably predicted survival and vital status, even after covariate adjustment.

Conclusions:

  • The HADO score provides an easily obtainable and effective method for classifying COPD severity in outpatient settings.
  • The HADO score demonstrates superior predictive capability for 3-year mortality compared to FEV1 alone.
  • HADO score offers a valuable tool for comprehensive COPD management and prognosis.